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C1q Production by Bone Marrow Stromal Cells
To the Editor
Complement components and their receptors have
recently come into focus as key regulators in the clear-
ance of apoptotic cells by human dendritic cells (DC), a
subset of phagocytic cells derived from bone marrow
stromal cell progenitors [1, 2]. C1q, the first component
of the classical pathway of complement activation, is able
to bind to the surface of apoptotic cells inducing C3b
deposition and promoting the uptake of apoptotic cells
by DC via the interaction with C1q receptor and other
C1q binding structures (Table 1) [3]. C1q production by
human DC has been reported to be restricted to imma-
ture DC in vitro, as it is downregulated upon DC matur-
ation [4]. In human bone marrow, active phagocytosis of
apoptotic cells and uptake of immune complexes, as well
as antigen presentation to lymphocytes, are provided by
stromal cells with dendritic morphology that are inter-
mingled with haematopoietic cells. These cells, hereafter
referred to as bone marrow stromal DC, contribute to the
formation of the bone marrow microenvironment actively
participating into the normal haematopoiesis through the
constitution of maturational niches [5]. They also have a
share in the composition of the bone marrow infiltrates
in lymphoid malignancies, although the underlying
mechanisms are still unknown [6]. We investigated the
expression of C1q in bone marrow stromal cells ex vivo
studying 17 bone marrow biopsies with normal histology
or non-specific reactive changes by immunohistochemis-
try and fluorescent in situ hybridization (FISH). By immu-
nohistochemical evaluation, C1q resulted strongly
expressed by bone marrow stromal DC (Fig. 1A) and by
macrophages (Fig. 1B) in all cases. These results were
confirmed by double stainings with CD1a (Fig. 1A,
inset) and CD68 (Fig. 1B, inset). FISH for C1q B chain
mRNA confirmed that C1q expression in bone marrow
stromal cells was due to direct production of C1q and
not to C1q uptake (Fig. 1C). Recently, a report by
Yamada et al. [7] demonstrated that C1q was able to sup-
press pro-inflammatory cytokine production (IL12p40,
TNF-a) by murine bone marrow-derived DC in vivo. This
Table 1 C1q binding structures and their functions.
Receptor Function
CR1 (CD35) Binds C1q and other complement derived opsonins (C4b, C3b, iC3b, MBL); involved in immune complex transfer
Calreticulin (CD91,
C1q receptor complex)
Cell surface receptor for the collagenous domains of C1q; uptake of apoptotic cells, induction of chemotaxis
gC1qbp Binding protein for the globular head of C1q
A
B C
Figure 1 (A) The few bone marrow dendritic
cells are positive to C1q (anti-C1q Dako, rab-
bit anti-human polyclonal antibody, 1:100;
original magnification 400·). CD1a staining
(inset) confirms their dendritic phenotype
(anti-CD1a Dako, mouse anti-human mono-
clonal antibody, 1:50; original magnification
400·). (B) C1q is also expressed by bone
marrow macrophages expressing CD68 (inset,
anti-CD68 Dako, mouse anti-human mono-
clonal antibody, 1:50; original magnification
400·). (C) The orange signal throughout
the cytoplasm of bone marrow stromal cells
represents C1q B-chain mRNA expression
(original magnification 400·).
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finding, together with our observation of C1q production
by bone marrow stromal cells, makes it possible to specu-
late on a role for C1q in the maintenance of bone marrow
homeostasis through an autocrine feedback system. These
results may add a valuable piece of information to the
current figure about the interactions between human
bone marrow stroma and the complement system.
References
1 Bajtay Z, Csomor E, Sandor N, Erdei A. Expression and role of FC-
and complement-receptors on human dendritic cells. Immunol Lett
2006;104:46–52.
2 Rossi M, Young JW. Human dendritic cells: potent antigen-pre-
senting cells at the crossroads of innate and adaptive immunity.
J Immunol 2005;175:1373–81.
3 Nauta AJ, Castellano G, Xu W et al. Opsonization with C1q and
mannose-binding lectin targets apoptotic cells to dendritic cells.
J Immunol 2004;173:3044–50.
4 Castellano G, Woltman AM, Nauta AJ et al. Maturation of dendritic
cells abrogates C1q production in vivo and in vitro. Blood
2004;103:3813–20.
5 Wilson A, Trumpp A. Bone-marrow haematopoietic-stem-cell niches.
Nat Rev Immunol 2006;6:93–106.
6 Foucar K. Non-Hodgkin lymphoma and Hodgkin lymphoma (dis-
ease) in bone marrow. In: Foucar K, ed. Bone Marrow Pathology, 2nd
edn. Chicago, IL: ASCP Press, 2001:439–83.
7 Yamada M, Oritani K, Kaisho T et al. Complement C1q regulates
LPS-induced cytokine production in bone marrow-derived dendritic
cells. Eur J Immunol 2004;34:221–30.
C. Tripodo, R. Porcasi, C. Guarnotta, S. Ingrao, V.
Campisi, A. M. Florena & V. Franco
Dipartimento di Patologia Umana, Palermo, Italy.
Correspondence to: C. Tripodo. Dipartimento di Patologia
Umana, via del Vespro, 129, 90100 Palermo, Italy.
E-mail: tripodo@unipa.it
 2007 The Authors
Journal compilation  2007 Blackwell Publishing Ltd. Scandinavian Journal of Immunology 65, 308–309
Letter to the Editor 309
..................................................................................................................................................................
